Identification of potential target genes of breast cancer in response to Chidamide treatment

Identification of potential target genes of breast cancer in response to Chidamide treatment

Chidamide, a new chemically structured HDACi-like drug, has been shown to inhibit breast cancer, but its specific mechanism has not been fully elucidated. In this paper, we selected ER-positive breast cancer MCF-7 cells and used RNA-seq technique to analyze the gene expression differences of Chidami...

Full description

Bibliographic Details
Main Authors: Han Han, Xue Feng, Yarui Guo, Meijia Cheng, Zhengguo Cui, Shanchun Guo, Weiqiang Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Molecular Biosciences
Subjects:
Chidamide
breast cancer
RNA-seq
bioinformatics
TP53
ACLY
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2022.999582/full

Internet

https://www.frontiersin.org/articles/10.3389/fmolb.2022.999582/full

Similar Items